Augurex Overview

  • Founded
  • 2006

Founded
  • Status
  • Private

  • Employees
  • 11

Employees
  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 3

Augurex General Information

Description

Developer of bio-marker blood tests designed to transform patient clinical management for improved disease outcomes. The company's bio-marker blood tests are based on point-of-care proprietary blood testing that connects with disease-specific applications and electronic health records, enabling doctors to optimize patient management by personalizing clinical decision-making.

Contact Information

Website
www.augurex.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Outcome Management (Healthcare)
Primary Office
  • 887 Great Northern Way
  • Suite 220
  • Vancouver, British Columbia V5T 4T5
  • Canada
+1 (604) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Augurex Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 25-Jan-2017 00000 Completed Generating Revenue
4. Angel (individual) 01-Feb-2011 000.00 00000 Completed Startup
3. Angel (individual) 01-May-2009 000.00 000.00 Completed Startup
2. Angel (individual) 01-Nov-2007 $52.8K $52.8K Completed Startup
1. Grant 01-Jan-2007 $52.8K Completed Startup
To view Augurex’s complete valuation and funding history, request access »

Augurex Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of bio-marker blood tests designed to transform patient clinical management for improved disease outcomes. The
Diagnostic Equipment
Vancouver, Canada
11 As of 2022
00000
0000000000 0 00000

000000

giat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deser
00000 0000000000 0000000000 0000000
Miami, FL
000 As of 0000
00000
000000000 00000

000000

in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat n
0000000000000
Boston, MA
000 As of 0000
00000
0000 0000-00-00
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Augurex Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BioTissue (Healthcare Technology Systems) Venture Capital-Backed Miami, FL 000 00000 000000000 00000
0000000 Venture Capital-Backed Boston, MA 000 00000 00000000000 00000
0000 0000 Venture Capital-Backed Burlingame, CA 00 000.00 00000000000 000.00
0000000 0000000000 Formerly VC-backed Redwood City, CA 000 00000 00000000000 00000
00000000 Accelerator/Incubator Backed Toulouse, France 00 0000000000
You’re viewing 5 of 10 competitors. Get the full list »

Augurex Executive Team (2)

Name Title Board Seat Contact Info
Norma Biln Co-Founder, Chief Executive Officer & Director
You’re viewing 1 of 2 executive team members. Get the full list »

Augurex Board Members (5)

Name Representing Role Since
David Demers Self Board Member 000 0000
Doug Buchanan Self Board Member 000 0000
Natalie Dakers Augurex Chairman 000 0000
Paul Terry Ph.D Self Board Member 000 0000
Tim Chan Self Board Member 000 0000
To view Augurex’s complete board members history, request access »

Augurex Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Augurex Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Genome British Columbia Not-For-Profit Venture Capital Minority 000 0000 000000 0
WUTIF Capital Angel Group Minority 000 0000 000000 0
New Ventures BC Accelerator/Incubator 000 0000 000000 0
To view Augurex’s complete investors history, request access »